Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia

NCT01662648 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1117

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Paliperidone ER

Sponsor

Janssen Pharmaceutica